89 related articles for article (PubMed ID: 2109591)
1. Immunosuppressive effect of misoprostol: a new synthetic prostaglandin E1 analogue.
Wiederkehr JC; Dumble L; Pollak R; Moran M
Aust N Z J Surg; 1990 Feb; 60(2):121-4. PubMed ID: 2109591
[TBL] [Abstract][Full Text] [Related]
2. Misoprostol with cyclosporin A prolongs corneal allograft survival in an animal model.
Olsen TW; Gothard TW; Holland EJ
Cornea; 1996 Jan; 15(1):76-81. PubMed ID: 8907385
[TBL] [Abstract][Full Text] [Related]
3. The effect of the prostaglandin analogues misoprostil and enisoprost on the synergy between donor-specific transfusion and cyclosporine in allograft survival.
Cofer BR; Davies CB; Alexander JW; Tchervenkov JI
Transplantation; 1992 Nov; 54(5):941-3. PubMed ID: 1440866
[No Abstract] [Full Text] [Related]
4. Effect of a PGE-1 analogue on the survival of cardiac transplant rats.
Gracida Juárez C; Mechor Ortíz JL; Mozes MF
Arch Med Res; 1992; 23(1):55-8. PubMed ID: 1308792
[TBL] [Abstract][Full Text] [Related]
5. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
6. Gramicidin as a potential immunosuppressant for organ transplantation: suppression of human lymphocyte blastogenesis in vitro and prolongation of heart allograft survival in the rat.
Hirano T; Oka K; Tamaki T
J Pharmacol Exp Ther; 1995 Apr; 273(1):223-9. PubMed ID: 7536243
[TBL] [Abstract][Full Text] [Related]
7. Prolongation of rat heart allograft survival using cyclosporine and enisoprost, a prostaglandin E1 analog.
Fabrega AJ; Blanchard J; Rivas PA; Moran SM; Pollak R
Transplantation; 1992 Jun; 53(6):1363-4. PubMed ID: 1604492
[No Abstract] [Full Text] [Related]
8. C. sinensis ablates allograft vasculopathy when used as an adjuvant therapy with cyclosporin A.
Jordan JL; Hirsch GM; Lee TD
Transpl Immunol; 2008 Jul; 19(3-4):159-66. PubMed ID: 18619544
[TBL] [Abstract][Full Text] [Related]
9. Leflunomide prolongs pulmonary allograft and xenograft survival.
Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive effects of leflunomide in a cardiac allograft model.
Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN
Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465
[No Abstract] [Full Text] [Related]
11. Statins induce immunosuppressive effect on heterotopic limb allografts in rat through inhibiting T cell activation and proliferation.
Nie C; Yang D; Liu G; Dong D; Ma Z; Fu H; Zhao Z; Sun Z
Eur J Pharmacol; 2009 Jan; 602(1):168-75. PubMed ID: 19041862
[TBL] [Abstract][Full Text] [Related]
12. Phenolic nortriterpene demethylzeylasteral: a new immunosuppressive component of Tripterygium Wilfordii Hook f.
Tamaki T; Kawamura A; Komatsu Y; Kawamura H; Maruyama H; Morota T
Transplant Proc; 1996 Jun; 28(3):1379-80. PubMed ID: 8658703
[No Abstract] [Full Text] [Related]
13. Sirolimus-mediated prolongation of rat cardiac allograft survival is enhanced by beta1 integrin very late antigen-4 blockade.
Vu MD; Qi S; Sehgal SN; Chen H; Kennedy JD
Transplant Proc; 2005; 37(1):162-3. PubMed ID: 15808581
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.
Cosenza CA; Cramer DV; Tuso PJ; Chapman FA; Wang HK; Makowka L
J Heart Lung Transplant; 1994; 13(3):489-97. PubMed ID: 8061026
[TBL] [Abstract][Full Text] [Related]
15. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
Williams JW; Xiao F; Foster P; Clardy C; McChesney L; Sankary H; Chong AS
Transplantation; 1994 Apr; 57(8):1223-31. PubMed ID: 8178350
[TBL] [Abstract][Full Text] [Related]
16. Effect of streptavidin on cardiac allograft prolongation is due to host T-Cell suppression.
Witkowski P; Fawwaz RA; Jin MX; DePaz HA; Oluwole OO; Hardy MA; Oluwole SF
Transplant Proc; 2005; 37(1):116-8. PubMed ID: 15808566
[TBL] [Abstract][Full Text] [Related]
17. A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine.
Aziz S; Tada Y; Gordon D; McDonald TO; Fareed J; Verrier ED
J Heart Lung Transplant; 1993; 12(4):634-43. PubMed ID: 8396435
[TBL] [Abstract][Full Text] [Related]
18. Didemnin B prolongs rat heart allograft survival.
Stevens DW; Jensen RM; Stevens LE
Transplant Proc; 1989 Feb; 21(1 Pt 1):1139-40. PubMed ID: 2650080
[No Abstract] [Full Text] [Related]
19. Combined treatment of glatiramer acetate and low doses of immunosuppressive drugs is effective in the prevention of graft rejection.
Aharoni R; Yussim A; Sela M; Arnon R
Int Immunopharmacol; 2005 Jan; 5(1):23-32. PubMed ID: 15589456
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of acute rejection after skin or cardiac transplantation by administration of donor antigens in the rat.
Shirouzu Y; Hikida S; Tanigawa H; Shirouzu K
Surg Today; 2004; 34(4):341-8. PubMed ID: 15052450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
